AbbVie [ABBV] vs Medicus Pharma [MDPLD] Detailed Stock Comparison

AbbVie Inc.

NYSE
Loading...

Medicus Pharma Ltd.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: AbbVie Inc. wins in 9 metrics, Medicus Pharma Ltd. wins in 2 metrics, with 1 ties. AbbVie Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric AbbVie Inc. Medicus Pharma Ltd. Better
P/E Ratio (TTM) 83.46 -1.47 AbbVie Inc.
Price-to-Book Ratio -108.79 3.90 Medicus Pharma Ltd.
Debt-to-Equity Ratio -21.19 0.10 Medicus Pharma Ltd.
PEG Ratio -0.01 N/A N/A
EV/EBITDA 14.31 0.00 Tie
Profit Margin (TTM) 6.91% 0.00% AbbVie Inc.
Operating Margin (TTM) 34.11% 0.00% AbbVie Inc.
EBITDA Margin (TTM) 34.11% N/A N/A
Return on Equity 6,225.00% -841.91% AbbVie Inc.
Return on Assets (TTM) 9.81% -358.37% AbbVie Inc.
Free Cash Flow (TTM) $17.82B $-4.16M AbbVie Inc.
Dividend Yield 3.10% N/A N/A
1-Year Return 19.18% N/A N/A
Price-to-Sales Ratio (TTM) 5.72 N/A N/A
Enterprise Value $418.50B $0 AbbVie Inc.
EV/Revenue Ratio 6.84 N/A N/A
Gross Profit Margin (TTM) 72.61% N/A N/A
Revenue per Share (TTM) $35 $0 AbbVie Inc.
Earnings per Share (Diluted) $2.37 $-2.54 AbbVie Inc.
Beta (Stock Volatility) 0.36 N/A N/A
Short % of Float 1.27% N/A N/A

AbbVie Inc. vs Medicus Pharma Ltd. Stock Performance Analysis

Loading Price Chart...

ABBV
MDPLD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
AbbVie Inc.0.04%2.58%8.40%22.13%18.90%10.98%
Medicus Pharma Ltd.1.78%0.00%0.00%0.00%0.00%0.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
AbbVie Inc.19.18%64.26%101.32%279.49%590.09%590.09%
Medicus Pharma Ltd.N/AN/AN/AN/AN/AN/A

Performance & Financial Health Analysis: AbbVie Inc. vs Medicus Pharma Ltd.

MetricABBVMDPLD
Market Information
Market Cap i$351.47BN/A
Market Cap CategoryMega capN/A
10 Day Avg. Volume i6,251,10120,091
90 Day Avg. Volume i6,859,58736,712
Last Close$254.49$2.86
52 Week Range$184.63 - $261.64$1.80 - $6.00
% from 52W High-2.73%-52.33%
All-Time High$261.64 (Jul 02, 2026)$3.00 (Jan 24, 2025)
% from All-Time High-2.73%-4.67%
Growth Metrics
Quarterly Revenue Growth0.10%N/A
Quarterly Earnings Growth0.10%N/A
Financial Health
Profit Margin (TTM) i0.07%0.00%
Operating Margin (TTM) i0.34%0.00%
Return on Equity (TTM) i62.25%-8.42%
Debt to Equity (MRQ) i-21.190.10
Cash & Liquidity
Book Value per Share (MRQ)$-1.85$0.73
Cash per Share (MRQ)$2.97N/A
Operating Cash Flow (TTM) i$19.03B$-4,987,008
Levered Free Cash Flow (TTM) i$18.34B$-6,784,140
Dividends
Last 12-Month Dividend Yield i3.10%N/A
Last 12-Month Dividend i$6.65N/A

Valuation & Enterprise Metrics Analysis: AbbVie Inc. vs Medicus Pharma Ltd.

MetricABBV (Apr 26, 2026)MDPLD (Mar 31, 2025)
Price Ratios
P/E Ratio (TTM) i83.46-1.47
Forward P/E i12.30N/A
PEG Ratio i-0.01N/A
Price to Sales (TTM) i5.72N/A
Price to Book (MRQ) i-108.793.90
Market Capitalization
Market Capitalization i$351.47B$22.45M
Enterprise Value i$418.50B$0
Enterprise Value Metrics
Enterprise to Revenue i6.84N/A
Enterprise to EBITDA i14.310.00
Risk & Other Metrics
Beta i0.36N/A
Book Value per Share (MRQ) i$-1.85$0.73

Financial Statements Comparison: AbbVie Inc. vs Medicus Pharma Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricABBV (2025)MDPLD (2023)
Revenue/Sales i61.16B0
Cost of Goods Sold i18.20BN/A
COGS % of Revenue i29.8%-
Gross Profit i42.96BN/A
Gross Margin i70.2%-
Research & Development i9.10B193,578
Operating Income (EBIT) i20.09B-3.01M
Operating Margin i32.8%-
EBITDA i22.70B-6.72M
EBITDA Margin i37.1%-
Pre-Tax Income i6.60B-6.78M
Pre-Tax Income % of Revenue i10.8%-
Income Tax i2.36BN/A
Income Tax % of Revenue i3.9%-
Net Income (Profit) i4.23B-6.78M
Profit Margin i6.9%-

Balance Sheet & Liquidity Metrics

MetricABBV (2025)MDPLD (2023)
Cash & Equivalents i5.23B1.72M
Total Current Assets i29.06B1.89M
Total Current Assets % of Revenue i47.5%-
Total Current Liabilities i43.29B1.09M
Total Current Liabilities % of Revenue i70.8%-
Long-Term Debt i58.94BN/A
Long-Term Debt % of Revenue i96.4%-
Total Shareholders Equity i-3.23B805,800
Retained Earnings i-15.49B-19.18M
Retained Earnings % of Revenue i-25.3%-
Property, Plant & Equipment i8.79BN/A

Cash Flow Statement Comparison

MetricABBV (2025)MDPLD (2023)
Operating Cash Flow i19.94B-4.99M
Operating Cash Flow % of Revenue i32.6%-
Capital Expenditures i-1.21BN/A
Free Cash Flow i17.82B-4.16M
FCF Margin i29.1%-
Debt Repayment i-9.60BN/A
Common Stock Repurchase i-980.00MN/A

Short Interest & Institutional Ownership Analysis

MetricABBVMDPLD
Shares Short i20.13MN/A
Short Ratio i2.67N/A
Short % of Float i1.27%N/A
Shares Outstanding i1.77B8.08M
Float Shares i1.77BN/A
% Held by Insiders i0.12%55.81%
% Held by Institutions i76.78%0.00%
% Held by Public i23.10%44.19%

Dividend Analysis & Yield Comparison: AbbVie Inc. vs Medicus Pharma Ltd.

MetricABBVMDPLD
Last 12-Month Dividend i$6.65N/A
Last 12-Month Dividend Yield i3.10%N/A
3-Year Avg Annual Dividend i$6.31N/A
3-Year Avg Dividend Yield i0.91%N/A
3-Year Total Dividends i$18.93N/A
Ex-Dividend DateJan 16, 2026N/A